Access
To read this story in full you will need to login or make a payment (see right).
Review
Nature Medicine 9, 669 - 676 (2003)
doi:10.1038/nm0603-669
The biology of VEGF and its receptors
Napoleone Ferrara1, Hans-Peter Gerber1 & Jennifer LeCouter1
Abstract
Vascular endothelial growth factor (VEGF) is a key regulator of physiological angiogenesis during embryogenesis, skeletal growth and reproductive functions. VEGF has also been implicated in pathological angiogenesis associated with tumors, intraocular neovascular disorders and other conditions. The biological effects of VEGF are mediated by two receptor tyrosine kinases (RTKs), VEGFR-1 and VEGFR-2, which differ considerably in signaling properties. Non-signaling co-receptors also modulate VEGF RTK signaling. Currently, several VEGF inhibitors are undergoing clinical testing in several malignancies. VEGF inhibition is also being tested as a strategy for the prevention of angiogenesis, vascular leakage and visual loss in age-related macular degeneration.
To read this story in full you will need to login or make a payment (see right).
